Black Americans are at higher risk for colorectal cancer than other racial or ethnic groups in the U.S. We can do better, and BOSS is leading the way.
The taskforce is a critical support to address the disparate impact of CRC in the Black community by increasing awareness and improving access to screening and supportive solutions, both during and after diagnosis.
BOSS efforts touch every aspect of a patient's path with colorectal cancer, with an ultimate goal of preventing it in the first place.
Black colorectal cancer patients often face unique barriers delaying their care. BOSS aims to increase colorectal screenings among Black individuals by addressing these disparities.
BOSS has led awareness campaigns, fundraised for research, advocated for under-resourced communities, and provided support.
BOSS and the Alliance plan to collaborate with various stakeholders to boost screenings by creating a sustainable program to detect potential undiagnosed cancers.
Disparities in colorectal screenings within the Black community exist for a few reasons.
American Cancer Society reported that “40 percent of the racial disparity in colon cancer survival is due to the combined effects of the later stage at diagnosis, more unfavorable tumor characteristics, and more comorbidities among black patients” (Lai et al, 2016).
Additional reasons include:
The Alliance is intentionally applying a health equity lens in its approach to improve colorectal screening rates of Black individuals. We partner with those closest to the challenge to identify equitable solutions. Our goal is to save lives and drive lasting impact.
BOSS members are passionate about raising CRC awareness in Black communities. Members can engage in local, regional, and national events, in addition to leadership opportunities.
The "Proud Supporter of the Colorectal Cancer Alliance" emblem is a high-resolution PNG graphic that anyone supporting the Alliance's mission to end colorectal cancer can display — digitally or in print.
As the nation observes Women's Health Month (beginning on Mother's Day) and Clinical Trials Awareness Month, the leading nonprofit Colorectal Cancer Alliance (Alliance) is calling on patients, caregivers, and healthcare providers to confront the urgent and underrecognized public health challenges that may be contributing to the rising death rates.
Asal Sayas, a force for good in public policy and a champion for patients, who worked for both a president and a senator, died Tuesday, April 21, after a defiant six-year path with young-onset colorectal cancer. She was 42 years old.